利妥昔单抗作为结节病的一种治疗选择。 - Suppr

Suppr

超能文献

Rituximab as a treatment alternative in sarcoidosis.

作者信息

Belkhou Ahlam, Younsi Rachid, El Bouchti Imane, El Hassani Selma

出版信息

Joint Bone Spine. 2008 Jul;75(4):511-2. doi: 10.1016/j.jbspin.2008.01.025. Epub 2008 Jun 17.

DOI:10.1016/j.jbspin.2008.01.025

PMID:18562234

Abstract

摘要

相似文献

Rituximab as a treatment alternative in sarcoidosis.

Joint Bone Spine. 2008 Jul;75(4):511-2. doi: 10.1016/j.jbspin.2008.01.025. Epub 2008 Jun 17.

Rituximab in rheumatic diseases.

Joint Bone Spine. 2007 Jan;74(1):4-6. doi: 10.1016/j.jbspin.2006.08.002. Epub 2006 Nov 13.

Lack of short-term efficacy of rituximab upon symptoms of ankylosing spondylitis treated for an associated vasculitis.

Joint Bone Spine. 2008 Jul;75(4):510-1. doi: 10.1016/j.jbspin.2008.01.023. Epub 2008 May 23.

Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis.

J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):771. doi: 10.1136/jnnp.2006.093567.

Rituximab in Graves' disease.

Eur J Endocrinol. 2008 Nov;159(5):515-6. doi: 10.1530/EJE-08-0630. Epub 2008 Aug 15.

Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry.

Ann Rheum Dis. 2010 Feb;69(2):471-2. doi: 10.1136/ard.2008.107102.

Successful treatment of cardiac sarcoidosis with infliximab.

J Rheumatol. 2008 Aug;35(8):1686-7.

Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al.

Arthritis Rheum. 2009 Sep 15;61(9):1281-2. doi: 10.1002/art.24726.

Negative clinical trials in sarcoidosis: failed therapies or flawed study design?

Eur Respir J. 2014 Nov;44(5):1123-6. doi: 10.1183/09031936.00156314.

Refractory neurosarcoidosis responding to infliximab.

Neurology. 2003 Apr 8;60(7):1220-1; author reply 1220-1. doi: 10.1212/wnl.60.7.1220-a.

引用本文的文献

Advance in pathogenesis of sarcoidosis: Triggers and progression.

Heliyon. 2024 Mar 8;10(5):e27612. doi: 10.1016/j.heliyon.2024.e27612. eCollection 2024 Mar 15.

Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action.

J Clin Med. 2023 Dec 19;13(1):15. doi: 10.3390/jcm13010015.

Maculopapular sarcoidosis: the importance of skin signs.

Dermatol Reports. 2022 Sep 16;15(1):9561. doi: 10.4081/dr.2022.9561. eCollection 2023 Mar 7.

Sarcoidosis: Progression to the chronic stage and pathogenic based treatment (narrative review).

Front Med (Lausanne). 2022 Sep 6;9:963435. doi: 10.3389/fmed.2022.963435. eCollection 2022.

Musculoskeletal Manifestations of Sarcoidosis.

Clin Med Insights Arthritis Musculoskelet Disord. 2022 Feb 14;15:11795441211072475. doi: 10.1177/11795441211072475. eCollection 2022.

Treatment of Sarcoidosis: A Multidisciplinary Approach.

Front Immunol. 2020 Nov 19;11:545413. doi: 10.3389/fimmu.2020.545413. eCollection 2020.

Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.

Front Immunol. 2020 Jul 14;11:1443. doi: 10.3389/fimmu.2020.01443. eCollection 2020.

Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases.

Am J Respir Crit Care Med. 2020 Oct 1;202(7):1013-1023. doi: 10.1164/rccm.201911-2151OC.

Imbalance in B cell and T Follicular Helper Cell Subsets in Pulmonary Sarcoidosis.

Sci Rep. 2020 Jan 23;10(1):1059. doi: 10.1038/s41598-020-57741-0.

Sarcoidosis as an Autoimmune Disease.

Front Immunol. 2020 Jan 8;10:2933. doi: 10.3389/fimmu.2019.02933. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Rituximab as a treatment alternative in sarcoidosis.

Joint Bone Spine. 2008 Jul;75(4):511-2. doi: 10.1016/j.jbspin.2008.01.025. Epub 2008 Jun 17.

Rituximab in rheumatic diseases.

Joint Bone Spine. 2007 Jan;74(1):4-6. doi: 10.1016/j.jbspin.2006.08.002. Epub 2006 Nov 13.

Lack of short-term efficacy of rituximab upon symptoms of ankylosing spondylitis treated for an associated vasculitis.

Joint Bone Spine. 2008 Jul;75(4):510-1. doi: 10.1016/j.jbspin.2008.01.023. Epub 2008 May 23.

Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis.

J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):771. doi: 10.1136/jnnp.2006.093567.

Rituximab in Graves' disease.

Eur J Endocrinol. 2008 Nov;159(5):515-6. doi: 10.1530/EJE-08-0630. Epub 2008 Aug 15.

Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry.

Ann Rheum Dis. 2010 Feb;69(2):471-2. doi: 10.1136/ard.2008.107102.

Successful treatment of cardiac sarcoidosis with infliximab.

J Rheumatol. 2008 Aug;35(8):1686-7.

Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al.

Arthritis Rheum. 2009 Sep 15;61(9):1281-2. doi: 10.1002/art.24726.

Negative clinical trials in sarcoidosis: failed therapies or flawed study design?

Eur Respir J. 2014 Nov;44(5):1123-6. doi: 10.1183/09031936.00156314.

Refractory neurosarcoidosis responding to infliximab.

Neurology. 2003 Apr 8;60(7):1220-1; author reply 1220-1. doi: 10.1212/wnl.60.7.1220-a.

引用本文的文献

Advance in pathogenesis of sarcoidosis: Triggers and progression.

Heliyon. 2024 Mar 8;10(5):e27612. doi: 10.1016/j.heliyon.2024.e27612. eCollection 2024 Mar 15.

Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action.

J Clin Med. 2023 Dec 19;13(1):15. doi: 10.3390/jcm13010015.

Maculopapular sarcoidosis: the importance of skin signs.

Dermatol Reports. 2022 Sep 16;15(1):9561. doi: 10.4081/dr.2022.9561. eCollection 2023 Mar 7.

Sarcoidosis: Progression to the chronic stage and pathogenic based treatment (narrative review).

Front Med (Lausanne). 2022 Sep 6;9:963435. doi: 10.3389/fmed.2022.963435. eCollection 2022.

Musculoskeletal Manifestations of Sarcoidosis.

Clin Med Insights Arthritis Musculoskelet Disord. 2022 Feb 14;15:11795441211072475. doi: 10.1177/11795441211072475. eCollection 2022.

Treatment of Sarcoidosis: A Multidisciplinary Approach.

Front Immunol. 2020 Nov 19;11:545413. doi: 10.3389/fimmu.2020.545413. eCollection 2020.

Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.

Front Immunol. 2020 Jul 14;11:1443. doi: 10.3389/fimmu.2020.01443. eCollection 2020.

Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases.

Am J Respir Crit Care Med. 2020 Oct 1;202(7):1013-1023. doi: 10.1164/rccm.201911-2151OC.

Imbalance in B cell and T Follicular Helper Cell Subsets in Pulmonary Sarcoidosis.

Sci Rep. 2020 Jan 23;10(1):1059. doi: 10.1038/s41598-020-57741-0.

Sarcoidosis as an Autoimmune Disease.

Front Immunol. 2020 Jan 8;10:2933. doi: 10.3389/fimmu.2019.02933. eCollection 2019.